365 related articles for article (PubMed ID: 15751086)
1. Erythropoietin reduces the degree of arthritis caused by type II collagen in the mouse.
Cuzzocrea S; Mazzon E; di Paola R; Genovese T; Patel NS; Britti D; de Majo M; Caputi AP; Thiemermann C
Arthritis Rheum; 2005 Mar; 52(3):940-50. PubMed ID: 15751086
[TBL] [Abstract][Full Text] [Related]
2. Reduction in the evolution of murine type II collagen-induced arthritis by treatment with rosiglitazone, a ligand of the peroxisome proliferator-activated receptor gamma.
Cuzzocrea S; Mazzon E; Dugo L; Patel NS; Serraino I; Di Paola R; Genovese T; Britti D; De Maio M; Caputi AP; Thiemermann C
Arthritis Rheum; 2003 Dec; 48(12):3544-56. PubMed ID: 14674008
[TBL] [Abstract][Full Text] [Related]
3. CGS 21680, an agonist of the adenosine (A2A) receptor, reduces progression of murine type II collagen-induced arthritis.
Mazzon E; Esposito E; Impellizzeri D; DI Paola R; Melani A; Bramanti P; Pedata F; Cuzzocrea S
J Rheumatol; 2011 Oct; 38(10):2119-29. PubMed ID: 21765105
[TBL] [Abstract][Full Text] [Related]
4. Absence of endogeneous interleukin-10 enhances the evolution of murine type-II collagen-induced arthritis.
Cuzzocrea S; Mazzon E; Dugo L; Serraino I; Britti D; De Maio M; Caputi AP
Eur Cytokine Netw; 2001; 12(4):568-80. PubMed ID: 11781183
[TBL] [Abstract][Full Text] [Related]
5. Oleuropein aglycone, an olive oil compound, ameliorates development of arthritis caused by injection of collagen type II in mice.
Impellizzeri D; Esposito E; Mazzon E; Paterniti I; Di Paola R; Morittu VM; Procopio A; Britti D; Cuzzocrea S
J Pharmacol Exp Ther; 2011 Dec; 339(3):859-69. PubMed ID: 21880869
[TBL] [Abstract][Full Text] [Related]
6. Glycogen synthase kinase-3beta inhibition attenuates the degree of arthritis caused by type II collagen in the mouse.
Cuzzocrea S; Mazzon E; Di Paola R; Muià C; Crisafulli C; Dugo L; Collin M; Britti D; Caputi AP; Thiemermann C
Clin Immunol; 2006 Jul; 120(1):57-67. PubMed ID: 16631408
[TBL] [Abstract][Full Text] [Related]
7. Ethyl pyruvate therapy attenuates experimental severe arthritis caused by type II collagen (CII) in the mouse (CIA).
Di Paola R; Mazzon E; Galuppo M; Esposito E; Bramanti P; Fink MP; Cuzzocrea S
Int J Immunopathol Pharmacol; 2010; 23(4):1087-98. PubMed ID: 21244758
[TBL] [Abstract][Full Text] [Related]
8. Type II collagen-induced arthritis in the diabetic-resistant biobreeding rat: inflammatory and histopathological features of joint pathology and effects of antiinflammatory and antirheumatic drugs on this chronic arthritic process.
Smith RJ; Sly LM
J Pharmacol Exp Ther; 1996 Jun; 277(3):1801-13. PubMed ID: 8667252
[TBL] [Abstract][Full Text] [Related]
9. Beneficial effects of tempol, a membrane-permeable radical scavenger, in a rodent model of collagen-induced arthritis.
Cuzzocrea S; McDonald MC; Mota-Filipe H; Mazzon E; Costantino G; Britti D; Mazzullo G; Caputi AP; Thiemermann C
Arthritis Rheum; 2000 Feb; 43(2):320-8. PubMed ID: 10693871
[TBL] [Abstract][Full Text] [Related]
10. Amelioration of joint disease in a rat model of collagen-induced arthritis by M40403, a superoxide dismutase mimetic.
Salvemini D; Mazzon E; Dugo L; Serraino I; De Sarro A; Caputi AP; Cuzzocrea S
Arthritis Rheum; 2001 Dec; 44(12):2909-21. PubMed ID: 11762952
[TBL] [Abstract][Full Text] [Related]
11. Cloricromene, a coumarine derivative, protects against collagen-induced arthritis in Lewis rats.
Cuzzocrea S; Mazzon E; Bevilaqua C; Costantino G; Britti D; Mazzullo G; De Sarro A; Caputi AP
Br J Pharmacol; 2000 Dec; 131(7):1399-407. PubMed ID: 11090113
[TBL] [Abstract][Full Text] [Related]
12. Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion.
Lubberts E; Koenders MI; Oppers-Walgreen B; van den Bersselaar L; Coenen-de Roo CJ; Joosten LA; van den Berg WB
Arthritis Rheum; 2004 Feb; 50(2):650-9. PubMed ID: 14872510
[TBL] [Abstract][Full Text] [Related]
13. Effects of combination M40403 and dexamethasone therapy on joint disease in a rat model of collagen-induced arthritis.
Cuzzocrea S; Mazzon E; Paola RD; Genovese T; Muià C; Caputi AP; Salvemini D
Arthritis Rheum; 2005 Jun; 52(6):1929-40. PubMed ID: 15934059
[TBL] [Abstract][Full Text] [Related]
14. Effect of tumor necrosis factor-related apoptosis-inducing ligand on the reduction of joint inflammation in experimental rheumatoid arthritis.
Jin CH; Chae SY; Kim TH; Yang HK; Lee EY; Song YW; Jo DG; Lee KC
J Pharmacol Exp Ther; 2010 Mar; 332(3):858-65. PubMed ID: 19933369
[TBL] [Abstract][Full Text] [Related]
15. Anticytokine treatment of established type II collagen-induced arthritis in DBA/1 mice: a comparative study using anti-TNFalpha, anti-IL-1alpha/beta and IL-1Ra.
Joosten LA; Helsen MM; van de Loo FA; van den Berg WB
Arthritis Rheum; 2008 Feb; 58(2 Suppl):S110-22. PubMed ID: 18240201
[TBL] [Abstract][Full Text] [Related]
16. Erythropoietin reduces the development of experimental inflammatory bowel disease.
Cuzzocrea S; Mazzon E; Di Paola R; Patel NS; Genovese T; Muià C; De Sarro A; Thiemermann C
J Pharmacol Exp Ther; 2004 Dec; 311(3):1272-80. PubMed ID: 15302898
[TBL] [Abstract][Full Text] [Related]
17. Polydeoxyribonucleotide reduces cytokine production and the severity of collagen-induced arthritis by stimulation of adenosine A(₂A) receptor.
Bitto A; Polito F; Irrera N; D'Ascola A; Avenoso A; Nastasi G; Campo GM; Micali A; Bagnato G; Minutoli L; Marini H; Rinaldi M; Squadrito F; Altavilla D
Arthritis Rheum; 2011 Nov; 63(11):3364-71. PubMed ID: 21769841
[TBL] [Abstract][Full Text] [Related]
18. Blockade of the interleukin-21/interleukin-21 receptor pathway ameliorates disease in animal models of rheumatoid arthritis.
Young DA; Hegen M; Ma HL; Whitters MJ; Albert LM; Lowe L; Senices M; Wu PW; Sibley B; Leathurby Y; Brown TP; Nickerson-Nutter C; Keith JC; Collins M
Arthritis Rheum; 2007 Apr; 56(4):1152-63. PubMed ID: 17393408
[TBL] [Abstract][Full Text] [Related]
19. An opposing time-dependent immune-modulating effect of the sympathetic nervous system conferred by altering the cytokine profile in the local lymph nodes and spleen of mice with type II collagen-induced arthritis.
Härle P; Möbius D; Carr DJ; Schölmerich J; Straub RH
Arthritis Rheum; 2005 Apr; 52(4):1305-13. PubMed ID: 15818682
[TBL] [Abstract][Full Text] [Related]
20. Palmitoylethanolamide and luteolin ameliorate development of arthritis caused by injection of collagen type II in mice.
Impellizzeri D; Esposito E; Di Paola R; Ahmad A; Campolo M; Peli A; Morittu VM; Britti D; Cuzzocrea S
Arthritis Res Ther; 2013; 15(6):R192. PubMed ID: 24246048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
